Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

NCT04282187 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Essential Thrombocythemia
Myelodysplastic Syndrome
Myelodysplastic/Myeloproliferative Neoplasm
Myeloproliferative Neoplasm
Myeloproliferative Neoplasm, Not Otherwise Specified
Polycythemia Vera
Primary Myelofibrosis
Secondary Myelofibrosis

Interventions

DRUG: Decitabine
DRUG: Ruxolitinib
DRUG: Fedratinib
OTHER: Questionnaire Administration
DRUG: Pacritinib
PROCEDURE: Biospecimen Collection

Sponsor

University of Washington